A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)
Celgene
Celgene
Amgen
Takeda
Incyte Corporation
M.D. Anderson Cancer Center
Amgen Research (Munich) GmbH
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Mayo Clinic
Alliance for Clinical Trials in Oncology
Amgen Research (Munich) GmbH
Baylor College of Medicine
Ariad Pharmaceuticals
Vanderbilt-Ingram Cancer Center
Mayo Clinic